Genomics Study in CML Patients With Ponatinib Treatment

Clinical trial NCT06945146 · COMPLETED

Trial details

NCT number: NCT06945146
Sponsor: Dong-Wook Kim
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Start date: 2020-09-01
Primary completion: 2024-08-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.